Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts.
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
Inogen, Inc. (INGN) Q1 2026 Earnings Call Transcript
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves
Inogen posts higher Q1 revenues and improved gross margin as international portable oxygen demand offsets weaker U.S. sales.
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.25 per share a year ago.
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN rides surging POC demand and global growth tailwinds, but U.S. channel shifts and macro risks may weigh on near-term performance.
Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?
Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Inogen (INGN) Up 6.8% Since Last Earnings Report: Can It Continue?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock?
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y
INGN posts narrower Q4 loss and 2% revenue rise, but shares dip as U.S. sales and rentals weaken despite international strength.
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $0.41 per share a year ago.
Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
Inogen (INGN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
